(layman's term not used by patient groups metabolic disease not applicable)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (see Protocol C1. page 10-11, paragraph 4.2 Inclusion criteria) - Age >= 16 years. - Written informed consent. - Cases: capacitated and incapacitated patients with a rare inherited metabolic disease, who are in care at UMCs and satellite expert centers. - Controls: healthy siblings and/or unrelated neighbors/ friends/ partners of the patients selected via the cases. List of diagnosis groups based on current patient population in the UMCs: - Urea cycle defects - Disorders of amino acid metabolism - Phenylketonuria - Homocystinuria - Glycogen overloading diseases - Mitochondropathy - Lysosomal overloading diseases - Fatty acid oxidation disorders - Disorders of glycosylation - Galactosemia - Peroxisomal disorders - Congenital hyperinsulinism - Porphyrias - Lipoprotein deficiencies - Disorders of vitamin metabolism - Disorders of glycosylation (CDG) - Rest of rare inherited metabolic diseases
Exclusion criteria
Exclusion criteria: (see Protocol C1. page 11) No signed 'informed consent' present.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (also see: C1. Protocol, page 11, paragraph 5.1.1) A metabolic bio-database, with DNA, blood samples, urine samples, faeces samples and hair samples from patients with inherited metabolic diseases, combined with the clinical and physical data. | — |
Secondary
| Measure | Time frame |
|---|---|
| (also see: C1. Protocol, page 11 and 12, paragraph 5.1.2) Clinical data: medication, history and symptoms, radiology data, other medical information such as endoscopies and surgery reports, and ECG. Disease specific or general questionnaires. Physical data: physical disabilities, neurological disorders, anthropometry, blood pressure, eye-hand coordination, activity level and pain level, and fundus. | — |
Countries
Netherlands